Correlation Between Beam Therapeutics and Biomarin Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beam Therapeutics and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Beam Therapeutics and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and Biomarin Pharmaceutical.

Diversification Opportunities for Beam Therapeutics and Biomarin Pharmaceutical

-0.01

Correlation Coefficient

Beam Therapeutics  Biomarin Pharmaceutical

Good diversification

The 3 months correlation between Beam and Biomarin is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and Biomarin Pharmaceutical go up and down completely randomly.

Pair Corralation between Beam Therapeutics and Biomarin Pharmaceutical

Given the investment horizon of 90 days Beam Therapeutics is expected to generate 4.47 times more return on investment than Biomarin Pharmaceutical. However, Beam Therapeutics is 4.47 times more volatile than Biomarin Pharmaceutical. It trades about 0.21 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about 0.01 per unit of risk. If you would invest  2,191  in Beam Therapeutics on September 1, 2024 and sell it today you would earn a total of  546.00  from holding Beam Therapeutics or generate 24.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Beam Therapeutics  vs.  Biomarin Pharmaceutical

Beam Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Beam Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Beam Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Biomarin Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biomarin Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Beam Therapeutics and Biomarin Pharmaceutical

The main advantage of trading using opposite Beam Therapeutics and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.

The idea behind Beam Therapeutics and Biomarin Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.